24 results
8-K
EX-99.1
PTPI
Petros Pharmaceuticals Inc
15 Aug 22
Petros Pharmaceuticals Reports Record Revenue and Gross Profit During Second Quarter 2022
9:16am
for Peyronie’s disease
Launched social media campaign with celebrity Physician Dr. Drew Pinsky.
“These financial results mark a critical milestone … to raise awareness in men’s health and STENDRA®, specifically, we recently engaged Dr. Drew Pinsky to kick off our social media campaign. Our objective
8-K
EX-10.1
PTPI
Petros Pharmaceuticals Inc
4 Mar 22
Departure of Directors or Certain Officers
5:00pm
by or through any forms of social media), Company, its present and former employees, officers, members, agents, directors, predecessors, successors, assigns
S-3
PTPI
Petros Pharmaceuticals Inc
29 Jan 21
Shelf registration
4:48pm
, such as pharmacy benefit managers, generic drug manufacturers, or from social or political activities, which would reduce our revenue and future profitability … -label even if not indicated for the orphan condition.
Petros may experience pricing pressure on the price of our products due to social or political
424B5
PTPI
Petros Pharmaceuticals Inc
15 Oct 21
Prospectus supplement for primary offering
5:01pm
managed care entities, such as pharmacy benefit managers, generic drug manufacturers, or from social or political activities, which would reduce our … products due to social or political pressure to lower the cost of drugs, which would reduce our revenue and future profitability, if achieved.
Federal
424B5
5v8 81ke6umu5sll
1 Dec 21
Prospectus supplement for primary offering
5:10pm
424B5
aqkvi1
23 Dec 21
Prospectus supplement for primary offering
5:01pm
8-K
EX-10.1
gpfkx2iffg8
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
8-K/A
EX-99.1
87e08fqy
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
EX-10.1
b40 9tpahf8v
13 Jul 23
Petros Pharmaceuticals Announces Capital Raise of $15 million
4:41pm
10-K
0r0 hby4u91fp092
31 Mar 21
Annual report
4:30pm
424B3
po0za4qefnra0c9d 29
2 Nov 20
Prospectus supplement
12:00am
S-4
60y4o
24 Jul 20
Registration of securities issued in business combination transactions
12:00am
10-K
EX-10.1
oas4tvhrszv 7gjsu
31 Mar 21
Annual report
4:30pm